Gene · 5587
Papers3,376
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,376
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AI-Assisted chemical probe discovery for the understudied Calcium-Calmodulin Dependent Kinase, PNCK. | PLoS Comput Biol | 2023 | 37235579 | PubTator, text mining | PubMed |
| Protein Kinase D1 Correlates with Less Lymph Node Metastasis Risk, Enhanced 5-FU Sensitivity, and Better Prognosis in Colorectal Cancer. | Tohoku J Exp Med | 2023 | 37225445 | PubTator, text mining | PubMed |
| New insights into signal transduction pathways in adrenal steroidogenesis: role of mitochondrial fusion, lipid mediators, and MAPK phosphatases. | Front Endocrinol (Lausanne) | 2023 | 37223023 | PubTator, text mining | PubMed |
| Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS. | Signal Transduct Target Ther | 2023 | 37221195 | PubTator, text mining | PubMed |
| Adiposity is associated with widespread transcriptional changes and downregulation of longevity pathways in aged skeletal muscle. | J Cachexia Sarcopenia Muscle | 2023 | 37199333 | PubTator, text mining | PubMed |
| β Cell and Autophagy: What Do We Know? | Biomolecules | 2023 | 37189396 | PubTator, text mining | PubMed |
| Small molecule inhibitor CRT0066101 inhibits cytokine storm syndrome in a mouse model of lung injury. | Int Immunopharmacol | 2023 | 37182445 | PubTator, text mining | PubMed |
| Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets. | Int J Mol Sci | 2023 | 37175869 | PubTator, text mining | PubMed |
| Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology. | Cancers (Basel) | 2023 | 37174125 | PubTator, text mining | PubMed |
| Depression and Hand-Grip: Unraveling the Association. | Cureus | 2023 | 37159619 | PubTator, text mining | PubMed |
| Condensation of the β-cell secretory granule luminal cargoes pro/insulin and ICA512 RESP18 homology domain. | Protein Sci | 2023 | 37159024 | PubTator, text mining | PubMed |
| Proteogenomic characterization of ferroptosis regulators reveals therapeutic potential in glioblastoma. | BMC Cancer | 2023 | 37158834 | PubTator, text mining | PubMed |
| Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications. | MedComm (2020) | 2023 | 37143582 | PubTator, text mining | PubMed |
| Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis. | Front Immunol | 2023 | 37138876 | PubTator, text mining | PubMed |
| Cofilin activation in pancreatic acinar cells plays a pivotal convergent role for mediating CCK-stimulated enzyme secretion and growth. | Front Physiol | 2023 | 37138671 | PubTator, text mining | PubMed |
| Pituitary Tumorigenesis-Implications for Management. | Medicina (Kaunas) | 2023 | 37109772 | PubTator, text mining | PubMed |
| Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA. | Int J Mol Sci | 2023 | 37108398 | PubTator, text mining | PubMed |
Verproside, the Most Active Ingredient in YPL-001 Isolated from Pseudolysimachion rotundum var. subintegrum, Decreases Inflammatory Response by Inhibiting PKCδ Activation in Human Lung Epithelial Cells. | Int J Mol Sci | 2023 | 37108390 | PubTator, text mining | PubMed |
| Research Progress on Autophagy Regulation by Active Ingredients of Traditional Chinese Medicine in the Treatment of Acute Lung Injury. | J Inflamm Res | 2023 | 37092134 | PubTator, text mining | PubMed |
| C. elegans dkf-1 (Protein Kinase D1) mutants have age-dependent defects in locomotion and neuromuscular transmission. | MicroPubl Biol | 2023 | 37090152 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5587/papers?page=13